Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorSir Mortimer B. Davis - Jewish General Hospital

About this trial

This project is being carried out to study the use of a medication to reduce nausea and vomiting after ear surgery.

Eligibility criteria

Qualifiers

Adult patients undergoing middle ear surgery including tympanoplasty with or without ossicular chain reconstruction, tympanomastoidectomy or stapedectomy

Patient using a hormonal contraceptive will be included, but warned aprepitant may reduce the efficacy of hormonal contraception thus an alternative or backup contraceptive methods should be used for one month after surgery

Disqualifiers

Children (<18 years old)

Patients unable to complete the post-procedure questionnaire (either due to time constraints, neurocognitive impairment, etc.)

Patients taking concomitant medications that are substrates, inhibitors or inducers of CYP3A4 or CYP2CP that are at risk of having a clinically significant effect

Patients with a history of hypersensitivity reaction to any of the medications used in the study

Trial design

Treatments tested in this trial

  • Aprepitant
  • Placebo

Treatment groups

100 Participants
are divided into 2 treatment groups